Rapt Therapeutics Stock Technical Analysis
| RAPT Stock | USD 8.04 0.09 1.11% |
As of the 18th of April 2024, RAPT Therapeutics holds the Variance of 134.27, market risk adjusted performance of (0.16), and Mean Deviation of 4.93. Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of RAPT Therapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the entity will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for RAPT Therapeutics, which can be compared to its competitors. Please check RAPT Therapeutics market risk adjusted performance and treynor ratio to decide if RAPT Therapeutics is priced more or less accurately, providing market reflects its current price of 8.04 per share. Given that RAPT Therapeutics has information ratio of (0.05), we recommend you to check out RAPT Therapeutics's recent market performance to make sure the company can sustain itself at some point in the future.
RAPT Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as RAPT, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RAPTRAPT |
RAPT Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 41.67 | Buy | 12 | Odds |
Most RAPT analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand RAPT stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of RAPT Therapeutics, talking to its executives and customers, or listening to RAPT conference calls.
RAPT Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
RAPT Therapeutics Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of RAPT Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
RAPT Therapeutics Trend Analysis
Use this graph to draw trend lines for RAPT Therapeutics. You can use it to identify possible trend reversals for RAPT Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual RAPT Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.RAPT Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for RAPT Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.35 , which may suggest that RAPT Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 4725.91, which is the sum of squared deviations for the predicted RAPT Therapeutics price change compared to its average price change.About RAPT Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of RAPT Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of RAPT Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on RAPT Therapeutics price pattern first instead of the macroeconomic environment surrounding RAPT Therapeutics. By analyzing RAPT Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of RAPT Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to RAPT Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Current Ratio | 20.11 | 7.41 | 14.56 | Net Debt To EBITDA | 0.35 | 0.33 | 0.31 |
RAPT Therapeutics April 18, 2024 Technical Indicators
Most technical analysis of RAPT help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for RAPT from various momentum indicators to cycle indicators. When you analyze RAPT charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 4.93 | |||
| Coefficient Of Variation | (2,109) | |||
| Standard Deviation | 11.59 | |||
| Variance | 134.27 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.71) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 79.19 | |||
| Value At Risk | (8.23) | |||
| Potential Upside | 6.87 | |||
| Skewness | (2.79) | |||
| Kurtosis | 28.75 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for RAPT Stock analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is RAPT Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.36) | Return On Equity (0.60) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.